| [1] |
Torre LA, Bray F, Siegel RL, et al. Global cancer statistic, 2012[J]. CA Cancer J Clin, 2015, 65(2): 87-108.
|
| [2] |
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: source, methods and major patterns in GLOBOCAN 2012[J]. Int J Cancer, 2015, 136(5): E359- E386.
|
| [3] |
Chen WQ, Zheng RS, Baade PD, et al. Cancer statistics in China, 2015[J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| [4] |
Li Q, Bao W, Fan Q, et al. Epidermal growth factor receptor kinase substrate 8 promotes the metastasis of cervical cancer via the epithelial-mesenchymal transition[J]. Mol Med Rep, 2016, 14(4): 3220-3228.
|
| [5] |
Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis[J]. Nature, 2001, 410(6824): 50-56.
|
| [6] |
Kryczek I, Lange A, Mottram P. CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers[J]. Cancer Res, 2005, 65(2): 465-472.
|
| [7] |
Kucia M, Jankowski K, Reca R, et al. CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion[J]. J Mol Histol, 2004, 35(3): 233-245.
|
| [8] |
Kajiyama H, Shibata K, Terauchi M, et al. Involvement of SDF-1a/CXCR4 axis in the enhanced peritoneal metastasis of epithelial ovarian carcinoma[J]. Int J Cancer, 2008, 122(1): 91-99.
|
| [9] |
Zou W, Machelon V, Coulomb-L′Hermin A, et al. Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells[J]. Nat Med, 2001, 7(12): 1339-1346.
|
| [10] |
Balabanian K, Lagane B, Infantino S, et al. The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes[J]. J Biol Chem, 2005, 280(42): 35760-35766.
|
| [11] |
Burns JM, Summers BC, Wang Y, et al. A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development[J]. J Exp Med, 2006, 203(9): 2201-2213.
|
| [12] |
Miao Z，Luker KE，Summers BC，et al. CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor associated vasculature[J]. Proc Natl Acad Sci USA, 2007, 104(40): 15735-15740.
|
| [13] |
Kurban S, Tursun M, Kurban G, et al. Role of CXCR7 and efforts on CXCL12 in Siha cells and upregulation in cervical squamous cell carinomas in Uighur women[J]. Asian Pac J Cancer Prev, 2014, 15(21): 9211-9216.
|
| [14] |
Liu Z, Yang L, Teng XY, et al. The involvement of CXCR7 in modulating the progression of papillary thyroid carcinoma[J]. J Surg Res, 2014, 191(2): 379-388.
|
| [15] |
Chow KY, Brotin E, Ben Khalifa Y, et al. A pivotal role for CXCL12 signaling in HPV-mediated transformation of keratinocytes: clues to understanding HPV-pathogenesis in WHIM syndrome[J]. Cell Host Microbe, 2010, 8(6): 523-533.
|
| [16] |
Shen-Gunther J, Wang CM, Poage GM, et al. Molecular pap smear: HPV genotype and DNA methylation of ADCY8, CDH8, and ZNF582 as an integrated biomarker for high-grade cervical cytology[J]. Clin Epigenetics, 2016, 8(1): 96-99.
|
| [17] |
Yu PF, Huang Y, Xu CL, et al. Downregulation of CXCL12 in mesenchymal stomal cells by TGF-β promotes breast cancer metastasis[J]. Oncogene, (2016-09-26)[2016-10-03].
URL
|
| [18] |
Boldajipour B，Mahabaleshwar H，Kardash E，et al.Control of chemokine-guided cell migration by ligand sequestration[J]. Cell, 2008, 132(3): 463-473.
|
| [19] |
Wang JH, Shiozawa YS, Wang JC, et al. The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-l in prostate cancer[J]. J Biol Chem, 2008, 283(7): 4283-4294.
|
| [20] |
Zur HH. Papillomaviruses and cancer: from basic studies to clinical application[J]. Nat Rev Cancer, 2002, 2(5): 342-350.
|